Here is the take home point:
In the current study, Dr. DeStefano, in collaboration with researchers from Kaiser Permanente; Harvard Medical School, in Boston, Massachusetts; Stanford University, in Palo Alto, California; and others reviewed records from a managed care organization. They also interviewed the parents of 256 children verified to have ASD according to a standardized personal evaluation.
Children with ASD were further classified into having autistic disorder or ASD with regression. The children with autism were matched by age, sex, and managed care organization to children without autism.
None of the autism outcomes were associated with prenatal or early-life receipt of thimerosal-containing vaccines and immunoglobulins, and the receipt of vaccines was comparable between patients with ASD and control patients.